1
|
Finance J, Zieleskewicz L, Habert P, Jacquier A, Parola P, Boussuges A, Bregeon F, Eldin C. Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19. J Clin Med 2021; 10:jcm10102196. [PMID: 34069557 PMCID: PMC8160936 DOI: 10.3390/jcm10102196] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Revised: 05/13/2021] [Accepted: 05/17/2021] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND The COVID-19 pandemic has provided an opportunity to use low- and non-radiating chest imaging techniques on a large scale in the context of an infectious disease, which has never been done before. Previously, low-dose techniques were rarely used for infectious diseases, despite the recognised danger of ionising radiation. METHOD To evaluate the role of low-dose computed tomography (LDCT) and lung ultrasound (LUS) in managing COVID-19 pneumonia, we performed a review of the literature including our cases. RESULTS Chest LDCT is now performed routinely when diagnosing and assessing the severity of COVID-19, allowing patients to be rapidly triaged. The extent of lung involvement assessed by LDCT is accurate in terms of predicting poor clinical outcomes in COVID-19-infected patients. Infectious disease specialists are less familiar with LUS, but this technique is also of great interest for a rapid diagnosis of patients with COVID-19 and is effective at assessing patient prognosis. CONCLUSIONS COVID-19 is currently accelerating the transition to low-dose and "no-dose" imaging techniques to explore infectious pneumonia and their long-term consequences.
Collapse
Affiliation(s)
- Julie Finance
- IRD, APHM, MEPHI, IHU Méditerranée Infection, Aix Marseille University, 13005 Marseille, France; (J.F.); (F.B.)
- Service des Explorations Fonctionnelles Respiratoires, APHM, 13005 Marseille, France
| | - Laurent Zieleskewicz
- Department of Anaesthesiology and Intensive Care Medicine, Hôpital Nord, APHM, Aix Marseille Université, 13005 Marseille, France;
- INRA, INSERM, Centre for Cardiovascular and Nutrition Research (C2VN), Aix Marseille Université, 13005 Marseille, France;
| | - Paul Habert
- Service de Radiologie Cardio-Thoracique, Hôpital La Timone, APHM, 13005 Marseille, France; (P.H.); (A.J.)
- LIIE, Aix Marseille University, 13005 Marseille, France
| | - Alexis Jacquier
- Service de Radiologie Cardio-Thoracique, Hôpital La Timone, APHM, 13005 Marseille, France; (P.H.); (A.J.)
- CNRS, CRMBM-CEMEREM (Centre de Résonance Magnétique Biologique et Médicale—Centre d’Exploration Métaboliques par Résonance Magnétique), APHM, Aix-Marseille University, UMR 7339, 13005 Marseille, France
| | - Philippe Parola
- IRD, APHM, SSA, VITROME, Aix Marseille University, 13005 Marseille, France;
- IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France
| | - Alain Boussuges
- INRA, INSERM, Centre for Cardiovascular and Nutrition Research (C2VN), Aix Marseille Université, 13005 Marseille, France;
| | - Fabienne Bregeon
- IRD, APHM, MEPHI, IHU Méditerranée Infection, Aix Marseille University, 13005 Marseille, France; (J.F.); (F.B.)
- Service des Explorations Fonctionnelles Respiratoires, APHM, 13005 Marseille, France
| | - Carole Eldin
- IRD, APHM, SSA, VITROME, Aix Marseille University, 13005 Marseille, France;
- IHU-Méditerranée Infection, Aix Marseille University, 13005 Marseille, France
- Correspondence:
| |
Collapse
|